Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Indivior planning to move primary listing to US, shares surge

(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US. Indivior said it was initiating consultations with shareholders on potentially shifting to a primary listing in the US this year, while maintaining a secondary listing in the UK.

The company said a US listing could be beneficial as it would "reflect the group's current and future growth opportunities for its proprietary treatments" - Sublocade, Perseries and Opvee - which are centred in the US.

In addition, it would attract more US investors and analysts and allow for inclusion in major US indices over time.

Indivior also pointed to the fact that a growing proportion of its share capital is owned by US-based investors.

News of the potential move came alongside 2023 results, which showed that operating losses narrowed to $4m from $85m a year earlier, while total net revenue rose 21% to $1.1bn.

At 0900 GMT, the shares were up 18.1% at 1,601p.

Russ Mould, investment director at AJ Bell, said: "Indivior is currently the forty-seventh largest company on the FTSE 250 index. One would expect it to receive a higher valuation on the US market and that's a key reason why many companies switch listing location.

"The company has nearly half of its shares owned by US investors and the US is one of its major sales regions so there is logic in having a US stock listing. However, it would be yet another blow to the reputation of the London Stock Exchange as a listing venue. The more companies that follow this path, the harder it will be to attract new names to the UK."

Share this article

Related Sharecast Articles

Canaccord Genuity lowers target price on Arrow Exploration
(Sharecast News) - Analysts at Canaccord Genuity lowered their target price on Colombia-focussed oil firm Arrow Exploration from 50.0p to 44.0p on Thursday but acknowledged that near-term drilling was likely to reboot production growth.
Comptoir brings back former CEO Hanna
(Sharecast News) - Comptoir Group announced the formal appointment of Chaker Hanna as its chief executive officer on Thursday, effective immediately.
Ralph Lauren lifts guidance, shares spike
(Sharecast News) - Fashion brand Ralph Lauren lifted annual revenue guidance after reporting better-than-expected third quarter earnings, as wealthy customers splashed out on its range of clothing, sending shares in the company 12% higher on Wall Street.
Vertu Motors warns FY profits will miss expectations, shares tank
(Sharecast News) - Vertu Motors tanked on Thursday as it warned that full-year adjusted pre-tax profit would be "significantly below" current market expectations as the UK government's zero emissions vehicle (ZEV) mandate is causing severe disruption in the new car market.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.